Complications in Hypertension and Obesity

N/AUnknownNCT00552292

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health30,000 enrolled

Overview

The study in aimed to investigate epidemiology of risk factors in Russian Federation its prognostic value aimed on acceptance of national specific definition of metabolic syndrome and guidelines for its management.

Study Type

OBSERVATIONAL

Enrollment

30,000

Conditions

Metabolic Syndrome Hypertension Obesity Dyslipidemia Hyperglycemia

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age older 18 years * Signed informed consent * Blood pressure more than 130 and/or 85 mm Hg * Waist circumference more than 80 sm in females and 94 in males and/or BMI more than 25 kg/m2 * Dyslipidemia (elevated TG and/or decreased level of HDLP or therapy for high triglyceride level) * Fasting glucose more than 5,6 mmol/l Exclusion Criteria: * Associated clinical conditions (stroke, TIA, MI, heart failure, renal disease, diabetes mellitus) * Severe concomitant diseases affecting outcome

Locations (1)

Almazov Federal Center of Heart, Blood and Endocrinology

Saint Petersburg, Russia

RECRUITING

Outcomes

Primary Outcomes

cardiovascular complications

Time frame: 2007-2017

Secondary Outcomes

diabetes mellitus

Time frame: 2007-2017

Central Contacts

Alexandra O Conrady, MD, PhD

CONTACT

+7812-70255-71 ahleague@mail.ru

Elena I Baranova, professor

CONTACT

346-9082 eibaranova@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.